Clinical Trial Update: An Observational Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer, Colon Cancer in the Adjuvant Setting, Advanced Gastric Cancer or Breast Cancer

View source ↗

Summary

An observational study of capecitabine (Xeloda) across metastatic colorectal cancer, adjuvant colon cancer, advanced gastric cancer, and breast cancer completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Gastric Cancer

Drugs mentioned

• Xeloda (capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer, Colorectal Cancer, Gastric Cancer | Status: COMPLETED | Results posted: 2016-05-02